Fondaction invests in DIEX Recherche to support the company's expansion and diversification of clinical trial services in Quebec.

Information on the Target

Fondaction has announced its investment in DIEX Recherche (DIEX) to support the company's expansion into new clinical trial sites and to diversify its range of services in clinical research. Established in 2006, DIEX has built a reputation for excellence in various research fields, including cardiovascular health, women's health, cognitive health, and the prevention of diseases and infections. The company collaborates with major pharmaceutical industry leaders such as Pfizer, Moderna, GSK, and Merck, conducting projects on an international scale.

DIEX currently operates six clinical trial sites across the province of Quebec, facilitating access to innovative treatments for patients, particularly those in rural areas beyond major urban centers. By working closely with numerous physician-researchers throughout Quebec, DIEX enhances participant recruitment, ensuring that a larger pool of patients benefits from the latest medical advancements, all while maintaining high standards of scientific rigor and patient safety.

Industry Overview in Canada

Clinical trials play a vital role in the research, development, and approval processes of new treatments. As Canada faces an aging population, there is a growing necessity to promote clinical research within the country to m